These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 21951283)
21. Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype. Laranjo M; Carvalho MJ; Costa T; Alves A; Oliveira RC; Casalta-Lopes J; Cordeiro P; Botas F; Abrantes AM; Paiva A; Oliveira C; Botelho MF Breast; 2018 Apr; 38():22-29. PubMed ID: 29182983 [TBL] [Abstract][Full Text] [Related]
22. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842 [TBL] [Abstract][Full Text] [Related]
23. The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines. Fujiwara D; Kato K; Nohara S; Iwanuma Y; Kajiyama Y Biochem Biophys Res Commun; 2013 May; 434(4):773-8. PubMed ID: 23602898 [TBL] [Abstract][Full Text] [Related]
24. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137 [TBL] [Abstract][Full Text] [Related]
25. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner. Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547 [TBL] [Abstract][Full Text] [Related]
26. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells. Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855 [TBL] [Abstract][Full Text] [Related]
27. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells. Yousefnia S; Naseri D; Seyed Forootan F; Tabatabaeian M; Moattar F; Ghafghazi T; Nasr Esfahani MH; Ghaedi K Clin Transl Oncol; 2020 Sep; 22(9):1619-1634. PubMed ID: 32056127 [TBL] [Abstract][Full Text] [Related]
28. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients. He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression analysis of mammospheres cultured from human breast cancers. Feifei N; Mingzhi Z; Yanyun Z; Huanle Z; Fang R; Mingzhu H; Mingzhi C; Yafei S; Fengchun Z J Cancer Res Clin Oncol; 2012 Nov; 138(11):1937-44. PubMed ID: 22752669 [TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated expression of MOAP-1, Bax and RASSF1A antagonizes chemo-drug resistance of human breast cancer cells expressing cancer stem cell markers. Tan EW; Abdullah ADI; Ming LC; Poh CL; Goh BH; Lau TP; Tan KO Biomed Pharmacother; 2024 Jul; 176():116744. PubMed ID: 38810399 [TBL] [Abstract][Full Text] [Related]
31. 3-O-methylfunicone, a secondary metabolite produced by Penicillium pinophilum, induces growth arrest and apoptosis in HeLa cells. Buommino E; Nicoletti R; Gaeta GM; Orlando M; Ciavatta ML; Baroni A; Tufano MA Cell Prolif; 2004 Dec; 37(6):413-26. PubMed ID: 15548174 [TBL] [Abstract][Full Text] [Related]
32. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438 [TBL] [Abstract][Full Text] [Related]
33. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells. Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042 [TBL] [Abstract][Full Text] [Related]
34. Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions. Debeb BG; Xu W; Mok H; Li L; Robertson F; Ueno NT; Reuben J; Lucci A; Cristofanilli M; Woodward WA Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):889-95. PubMed ID: 20159363 [TBL] [Abstract][Full Text] [Related]
35. Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression. Jung JW; Park SB; Lee SJ; Seo MS; Trosko JE; Kang KS PLoS One; 2011; 6(11):e28068. PubMed ID: 22132214 [TBL] [Abstract][Full Text] [Related]
36. Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53. Ahn YT; Kim MS; Kim YS; An WG Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33233699 [TBL] [Abstract][Full Text] [Related]
37. 5-Desmethylsinensetin isolated from Artemisia princeps suppresses the stemness of breast cancer cells via Stat3/IL-6 and Stat3/YAP1 signaling. Liu R; Choi HS; Ko YC; Yun BS; Lee DS Life Sci; 2021 Sep; 280():119729. PubMed ID: 34146553 [TBL] [Abstract][Full Text] [Related]
38. Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression. Nasr M; Farghaly M; Elsaba T; El-Mokhtar M; Radwan R; Elsabahy M; Abdelkareem A; Fakhry H; Mousa N Int J Biochem Cell Biol; 2018 Dec; 105():84-93. PubMed ID: 30359767 [TBL] [Abstract][Full Text] [Related]
39. A High-Throughput Image Cytometry Method for the Formation, Morphometric, and Viability Analysis of Drug-Treated Mammospheres. Kessel SL; Chan LL SLAS Discov; 2020 Aug; 25(7):723-733. PubMed ID: 32396489 [TBL] [Abstract][Full Text] [Related]
40. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b. Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]